Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:52 UTC |
---|
Update Date | 2022-03-07 02:52:01 UTC |
---|
HMDB ID | HMDB0015534 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Nitrazepam |
---|
Description | Nitrazepam is only found in individuals that have used or taken this drug. It is a benzodiazepine derivative used as an anticonvulsant and hypnotic.Nitrazepam belongs to a group of medicines called benzodiazepines. It acts on benzodiazepine receptors in the brain which are associated with the GABA receptors causing an enhanced binding of GABA (gamma amino butyric acid) to GABAA receptors. GABA is a major inhibitory neurotransmitter in the brain, involved in inducing sleepiness, muscular relaxation and control of anxiety and fits, and slows down the central nervous system. The anticonvulsant properties of nitrazepam and other benzodiazepines may be in part or entirely due to binding to voltage-dependent sodium channels rather than benzodiazepine receptors. Sustained repetitive firing seems to be limited by benzodiazepines effect of slowing recovery of sodium channels from inactivation. |
---|
Structure | [O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2)C=C1 InChI=1S/C15H11N3O3/c19-14-9-16-15(10-4-2-1-3-5-10)12-8-11(18(20)21)6-7-13(12)17-14/h1-8H,9H2,(H,17,19) |
---|
Synonyms | Value | Source |
---|
1,3-Dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one | ChEBI | 2,3-Dihydro-7-nitro-5-phenyl-1H-1,4-benzodiazepin-2-one | ChEBI | 7-Nitro-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one | ChEBI | 7-Nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one | ChEBI | Apodorm | ChEBI | Atempol | ChEBI | Benzalin | ChEBI | Calsmin | ChEBI | Dormicum | ChEBI | Eatan | ChEBI | Eunoctin | ChEBI | Gerson | ChEBI | Hipnax | ChEBI | Hipsal | ChEBI | Ibrovek | ChEBI | Imeson | ChEBI | Imesont | ChEBI | Mogadon | ChEBI | N-Desmethylnimetazepam | ChEBI | Nelbon | ChEBI | Nelmat | ChEBI | Neozepam | ChEBI | Neuchlonic | ChEBI | Nitrados | ChEBI | Nitrazepamum | ChEBI | Paxisyn | ChEBI | Pelson | ChEBI | Persopit | ChEBI | Radedorm | ChEBI | Relact | ChEBI | Remnos | ChEBI | Ro 4-5360 | ChEBI | Ro 5-3059 | ChEBI | Somitran | ChEBI | Sonebon | ChEBI | Sonnolin | ChEBI | Surem | ChEBI | Trazenin | ChEBI | Unisomnia | ChEBI | 1, 3-Dihydro-7-nitro-5-phenyl-2H-1,4-benzodiazepin-2-one | HMDB | 2,3-Dihydro-7-nitro-5-phenyl-1H-1,4-benzodiazepin-2-ON | HMDB | 7-Nitro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one | HMDB | Alter brand OF nitrazepam | HMDB | CSP Brand OF nitrazepam | HMDB | DDSA brand OF nitrazepam | HMDB | Desitin brand OF nitrazepam | HMDB | Nitrazepam al | HMDB | Nitrazepam-neuraxpharm | HMDB | Nitrodiazepam | HMDB | Novanox | HMDB | Taurus brand OF nitrazepam | HMDB | CT-Arzneimittel brand OF nitrazepam | HMDB | Aliud brand OF nitrazepam | HMDB | Alphapharma brand OF nitrazepam | HMDB | Dormicum brand OF nitrazepam | HMDB | Nitrazadon | HMDB | Nitrazep | HMDB | Norgine brand OF nitrazepam | HMDB | Rhoxalpharma brand OF nitrazepam | HMDB | Scheurich brand OF nitrazepam | HMDB | Serenade | HMDB | Dermatech brand OF nitrazepam | HMDB | ICN brand OF nitrazepam | HMDB | Imadorm | HMDB | Pfleger brand OF nitrazepam | HMDB | Rhoxal-nitrazepam | HMDB | Wernigerode brand OF nitrazepam | HMDB | Allphar brand OF nitrazepam | HMDB | Alodorm | HMDB | Alpharma brand OF nitrazepam | HMDB | Dormalon | HMDB | Dormo-puren | HMDB | Protea brand OF nitrazepam | HMDB | Somnite | HMDB | United drug brand OF nitrazepam | HMDB | Neuraxpharm brand OF nitrazepam | HMDB | Rhoxal nitrazepam | HMDB | Nitrazepam neuraxpharm | HMDB |
|
---|
Chemical Formula | C15H11N3O3 |
---|
Average Molecular Weight | 281.2661 |
---|
Monoisotopic Molecular Weight | 281.080041233 |
---|
IUPAC Name | 7-nitro-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one |
---|
Traditional Name | gerson |
---|
CAS Registry Number | 146-22-5 |
---|
SMILES | [O-][N+](=O)C1=CC2=C(NC(=O)CN=C2C2=CC=CC=C2)C=C1 |
---|
InChI Identifier | InChI=1S/C15H11N3O3/c19-14-9-16-15(10-4-2-1-3-5-10)12-8-11(18(20)21)6-7-13(12)17-14/h1-8H,9H2,(H,17,19) |
---|
InChI Key | KJONHKAYOJNZEC-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as 1,4-benzodiazepines. These are organic compounds containing a benzene ring fused to a 1,4-azepine. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Benzodiazepines |
---|
Sub Class | 1,4-benzodiazepines |
---|
Direct Parent | 1,4-benzodiazepines |
---|
Alternative Parents | |
---|
Substituents | - 1,4-benzodiazepine
- Alpha-amino acid or derivatives
- Nitroaromatic compound
- Monocyclic benzene moiety
- Benzenoid
- Carboxamide group
- Ketimine
- Lactam
- C-nitro compound
- Organic nitro compound
- Secondary carboxylic acid amide
- Carboxylic acid derivative
- Azacycle
- Organic oxoazanium
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Allyl-type 1,3-dipolar organic compound
- Organic oxygen compound
- Hydrocarbon derivative
- Organic oxide
- Imine
- Organonitrogen compound
- Organooxygen compound
- Carbonyl group
- Organic zwitterion
- Organopnictogen compound
- Organic nitrogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 225 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.03 g/L | Not Available | LogP | 2.25 | HANSCH,C ET AL. (1995) |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross SectionsAdduct Type | Data Source | CCS Value (Å2) | Reference |
---|
[M+H]+ | CBM | 163.6 | 30932474 |
|
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times UnderivatizedChromatographic Method | Retention Time | Reference |
---|
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 4.22 minutes | 32390414 | Predicted by Siyang on May 30, 2022 | 12.1193 minutes | 33406817 | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.17 minutes | 32390414 | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 28.5 seconds | 40023050 | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1771.2 seconds | 40023050 | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 329.7 seconds | 40023050 | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 141.7 seconds | 40023050 | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 185.1 seconds | 40023050 | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 101.6 seconds | 40023050 | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 404.8 seconds | 40023050 | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 583.4 seconds | 40023050 | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 70.1 seconds | 40023050 | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 1077.5 seconds | 40023050 | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 404.2 seconds | 40023050 | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1198.4 seconds | 40023050 | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 352.4 seconds | 40023050 | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 357.3 seconds | 40023050 | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 312.9 seconds | 40023050 | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 228.4 seconds | 40023050 | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 56.8 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Nitrazepam,1TMS,isomer #1 | C[Si](C)(C)N1C(=O)CN=C(C2=CC=CC=C2)C2=CC([N+](=O)[O-])=CC=C21 | 2549.5 | Semi standard non polar | 33892256 | Nitrazepam,1TMS,isomer #1 | C[Si](C)(C)N1C(=O)CN=C(C2=CC=CC=C2)C2=CC([N+](=O)[O-])=CC=C21 | 2621.7 | Standard non polar | 33892256 | Nitrazepam,1TMS,isomer #1 | C[Si](C)(C)N1C(=O)CN=C(C2=CC=CC=C2)C2=CC([N+](=O)[O-])=CC=C21 | 3693.9 | Standard polar | 33892256 | Nitrazepam,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)CN=C(C2=CC=CC=C2)C2=CC([N+](=O)[O-])=CC=C21 | 2822.0 | Semi standard non polar | 33892256 | Nitrazepam,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)CN=C(C2=CC=CC=C2)C2=CC([N+](=O)[O-])=CC=C21 | 2822.3 | Standard non polar | 33892256 | Nitrazepam,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N1C(=O)CN=C(C2=CC=CC=C2)C2=CC([N+](=O)[O-])=CC=C21 | 3749.7 | Standard polar | 33892256 |
|
---|